169 related articles for article (PubMed ID: 12133763)
21. Atorvastatin pleiotropic effects mediated via suppression of TNF-alpha in congestive heart failure patients with initial normal TNF-alpha levels.
Kotyla PJ
J Heart Lung Transplant; 2009 Jan; 28(1):114-5. PubMed ID: 19134543
[No Abstract] [Full Text] [Related]
22. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
Schwartz GG; Bolognese MA; Tremblay BP; Caplan R; Hutchinson H; Raza A; Cressman M
Am Heart J; 2004 Jul; 148(1):e4. PubMed ID: 15215813
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
[TBL] [Abstract][Full Text] [Related]
24. Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia.
Sakabe K; Fukuda N; Wakayama K; Nada T; Shinohara H; Tamura Y
Am J Cardiol; 2004 Aug; 94(4):497-500. PubMed ID: 15325939
[TBL] [Abstract][Full Text] [Related]
25. Atorvastatin (Lipitor).
Tucker G
Conn Med; 1998 May; 62(5):283-5. PubMed ID: 9639958
[No Abstract] [Full Text] [Related]
26. [Aggressive therapy and combination therapy in severe hyperlipidemia].
Kostner KM
Wien Med Wochenschr; 1999; 149(5-6):146-8. PubMed ID: 10408007
[TBL] [Abstract][Full Text] [Related]
27. Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?
Athyros VG; Tziomalos K; Karagiannis A; Wierzbicki AS; Mikhailidis DP
Curr Opin Cardiol; 2010 Jul; 25(4):406-10. PubMed ID: 20375883
[TBL] [Abstract][Full Text] [Related]
28. [Myopathy due to deficiency of desaminase myoadenilate induced by atorvastatine].
García-Estévez DA; San Millán B; Navarro C; Sogo T
Med Clin (Barc); 2013 Jun; 140(12):565-7. PubMed ID: 23337446
[No Abstract] [Full Text] [Related]
29. Atorvastatin: a hydroxymethylglutaryl-coenzyme A reductase inhibitor.
Malinowski JM
Am J Health Syst Pharm; 1998 Nov; 55(21):2253-67; quiz 2302-3. PubMed ID: 9825877
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
Jones PH; Davidson MH; Stein EA; Bays HE; McKenney JM; Miller E; Cain VA; Blasetto JW;
Am J Cardiol; 2003 Jul; 92(2):152-60. PubMed ID: 12860216
[TBL] [Abstract][Full Text] [Related]
31. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of a generic and a branded formulation of atorvastatin 20 mg/d in hypercholesterolemic Korean adults at high risk for cardiovascular disease: a multicenter, prospective, randomized, double-blind, double-dummy clinical trial.
Kim SH; Park K; Hong SJ; Cho YS; Sung JD; Moon GW; Yoon MH; Lee MY; Hyon MS; Kim DW; Kim HS
Clin Ther; 2010 Oct; 32(11):1896-905. PubMed ID: 21095484
[TBL] [Abstract][Full Text] [Related]
33. Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial.
Bone HG; Kiel DP; Lindsay RS; Lewiecki EM; Bolognese MA; Leary ET; Lowe W; McClung MR
J Clin Endocrinol Metab; 2007 Dec; 92(12):4671-7. PubMed ID: 17726081
[TBL] [Abstract][Full Text] [Related]
34. [Effectiveness of atorvastatin compared to other statins of usual clinical practice in primary care].
Sicras Mainar A; Navarro Artieda R; Fernández de Bobadilla J; Checa JC
Med Clin (Barc); 2006 Oct; 127(14):555-6. PubMed ID: 17145005
[No Abstract] [Full Text] [Related]
35. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
[TBL] [Abstract][Full Text] [Related]
36. The nature of the statins.
Jones PH
Circulation; 2000 Feb; 101(8):E89. PubMed ID: 10694539
[No Abstract] [Full Text] [Related]
37. [Proximal myopathy secondary to statin treatment in a patient with Hashimoto thyroiditis].
Ferreiro JL; Dapena Mdel C; Suárez RL; Pérez-Argüelles BS; Vázquez CM
Endocrinol Nutr; 2009; 56(7):387. PubMed ID: 19883901
[No Abstract] [Full Text] [Related]
38. Chronic urticaria to atorvastatin.
Anliker MD; Wüthrich B
Allergy; 2002 Apr; 57(4):366. PubMed ID: 11906371
[No Abstract] [Full Text] [Related]
39. Benefits and menaces related to the use of statins in patients after renal transplantation.
Chmielewski M; Zdrojewski Z; Rutkowski B
Ann Transplant; 2002; 7(2):6-10. PubMed ID: 12416466
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women.
Issa MH; Cerda A; Genvigir FD; Cavalli SA; Bertolami MC; Faludi AA; Hirata MH; Hirata RD
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):139-44. PubMed ID: 22094353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
